Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis
Aims We have previously reported that Centchroman (CC), an oral contraceptive drug,
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis.
K Sajid, S Samriddhi, F Mohammad, S Sonam… - Life Sciences, 2020 - ir.cftri.res.in
Aims We have previously reported that Centchroman (CC), an oral contraceptive drug,
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis
S Khan, S Shukla, M Farhan, S Sinha, AD Lakra… - Life …, 2020 - scholars.uthscsa.edu
Aims: We have previously reported that Centchroman (CC), an oral contraceptive drug,
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
[PDF][PDF] Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis
S Khan, S Shukla, M Farhan, S Sinha, AD Lakra… - academia.edu
Aims We have previously reported that Centchroman (CC), an oral contraceptive drug,
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis
S Khan, S Shukla, M Farhan, S Sinha… - Life …, 2020 - pubmed.ncbi.nlm.nih.gov
Aims We have previously reported that Centchroman (CC), an oral contraceptive drug,
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis.
S Khan, S Shukla, M Farhan, S Sinha, AD Lakra… - Life …, 2020 - europepmc.org
Aims We have previously reported that Centchroman (CC), an oral contraceptive drug,
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis.
K Sajid, S Samriddhi, F Mohammad, S Sonam… - Life Sciences, 2020 - ir.cftri.res.in
Aims We have previously reported that Centchroman (CC), an oral contraceptive drug,
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
[PDF][PDF] Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis
S Khan, S Shukla, M Farhan, S Sinha, AD Lakra… - academia.edu
Aims We have previously reported that Centchroman (CC), an oral contraceptive drug,
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …
inhibits breast cancer progression and metastasis. In this study, we investigated whether CC …